Skip to main content
. 2018 Mar 8;13(4):604–611. doi: 10.2215/CJN.07470717

Table 1.

Physicochemical properties and dialyzability statements for study β-blockers

β-Blocker Physicochemical Properties Industry Statements Review Articles Expected Dialyzability
Product Monographs Dialysis of Drugs 2013a Levin et al. (21) Chazot and Jean (19) Chen et al. (20) Redon et al. (22)
Atenolol Molecular mass: 266 D Moderately dialyzable (20%–50%) Conventional HD: yes; modern HD: likely D D D D High dialyzability
Water solubility: 13,500 mg/L
Protein binding: 10%
VD: 4.2 L/kg
Metoprolol Molecular mass: 267 D No statement Conventional HD: yes; modern HD: likely D D D ND High dialyzability
Water solubility: 16,900 mg/L
Protein binding: 10%
VD: 3.2 L/kg
Bisoprolol Molecular mass: 325 D Not dialyzable Conventional HD: yes; modern HD: no data ND ND ND ND Low dialyzability
Water solubility: 2,240 mg/L
Protein binding: 30%
VD: 3.0 L/kg
Carvedilol Molecular mass: 406 D Not dialyzable Conventional HD: no; modern HD: unlikely ND ND ND ND Low dialyzability
Water solubility: 0.583 mg/L
Protein binding: >98%
VD: 1.6 L/kg

Yes indicates that dialysis was found to enhance drug clearance from previously published studies. No indicates that dialysis was not found to enhance drug clearance from previously published studies. No data indicate that no data or assumptions from physicochemical properties exist to describe drug dialyzability. Likely drug is likely to be cleared by HD on the basis of physicochemical parameters, but no data exist. Unlikely drug is unlikely to be cleared by HD on the basis of physicochemical parameters, but no data exist. VD, volume of distribution; HD, hemodialysis; D, drug is listed as dialyzable in corresponding review article; ND, drug is listed as not dialyzable in corresponding review article.

a

Annual guidelines published by Renal Pharmacy Consultants, LLC (Saline, MI). Dialyzability is on the basis of scientific and industry data.